World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
22309
World Ranking
19083
National Ranking
218

Overview

Vesa Kataja is affiliated with the University of Eastern Finland in Finland and works primarily in the field of Medicine. Their research encompasses multiple subfields including Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging, and Economics and Econometrics.

Kataja's work spans a variety of topics related to cancer and medical research. Key areas of focus include:

  • Cancer survivorship and care
  • Colorectal cancer treatments and studies
  • Prostate cancer treatment and research
  • Radiomics and machine learning in medical imaging
  • Cancer treatment and pharmacology
  • Cancer immunotherapy and biomarkers
  • Economic and financial impacts of cancer

The scientist frequently publishes research in several journals, with repeated contributions to:

  • Annals of Oncology
  • Research Square (Research Square)
  • Journal of Clinical Oncology
  • Radiotherapy and Oncology
  • BMC Medical Informatics and Decision Making

Some recent representative papers authored or coauthored by Vesa Kataja include:

  • "Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies" (2021, BMC Medical Informatics and Decision Making)
  • "Stereotactic body radiotherapy for localized prostate cancer - 5-year efficacy results" (2020, Radiation Oncology)
  • "A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland" (2022, Journal of Pharmaceutical Policy and Practice)
  • "Biweekly Cabazitaxel Is a Safe Treatment Option for Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients After Docetaxel - A Final Analysis of the Prosty II Trial" (2020, Anticancer Research)
  • "Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data" (2022, Applied Sciences)

Kataja has collaborated extensively with several frequent coauthors, including:

  • Jussi Ekström
  • Henri Virtanen
  • Sanna Iivanainen
  • Jussi Koivunen
  • Santeri Mentu

Best Publications

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

    Heikki Joensuu;Pirkko-Liisa Kellokumpu-Lehtinen;Petri Bono;Tuomo Alanko

  • Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    S. Loi;S. Loi;S. Michiels;S. Michiels;R. Salgado;N. Sirtaine

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

    Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch

  • A common coding variant in CASP8 is associated with breast cancer risk

    Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian

  • Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • MicroRNA related polymorphisms and breast cancer risk

    Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne

  • Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

    Heikki Joensuu;Petri Bono;Vesa Kataja;Tuomo Alanko

  • Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

    Shahana Ahmed;Gilles Thomas;Maya Ghoussaini;Catherine S. Healey

  • A recurrent mutation in PALB2 in Finnish cancer families

    Hannele Erkko;Bing Xia;Jenni Nikkilä;Johanna Schleutker

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    A. Horwich;C. Parker;Chris Bangma;Vesa Kataja

  • Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

    Montserrat Garcia-Closas;Per Hall;Heli Nevanlinna;Karen Pooley

  • Genome-wide association studies identify four ER negative-specific breast cancer risk loci

    Montserrat Garcia-Closas;Fergus J. Couch;Sara Lindstrom;Kyriaki Michailidou

  • Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

    Johanna M. Pellikainen;Kirsi M. Ropponen;Vesa V. Kataja;Jari K. Kellokoski

  • A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer

    Alison M. Dunning;Peter D. Ellis;Simon McBride;Heidi L Kirschenlohr

  • Genome-wide association analysis identifies three new breast cancer susceptibility loci

    Maya Ghoussaini;Olivia Fletcher;Kyriaki Michailidou;Clare Turnbull

Frequent Co-Authors

Veli-Matti Kosma
Veli-Matti Kosma University of Eastern Finland
Graham G. Giles
Graham G. Giles University of Melbourne
Arto Mannermaa
Arto Mannermaa University of Eastern Finland
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Barbara Burwinkel
Barbara Burwinkel Heidelberg University
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond traditional medical school, a range of flexible online programs is available. These programs can accelerate your path to a rewarding medical profession or provide a stepping stone to advanced roles.

Nursing candidates looking to expand their qualifications without interrupting their work life might explore rn to bsn no clinical hours programs, which skip traditional in-person clinical requirements. If you’re aiming for the highest levels of nursing practice, consider the fastest online dnp programs for a quicker route to a Doctor of Nursing Practice degree. Many dnp online programs also offer flexibility and streamlined admission requirements, making them accessible for working professionals.

For those seeking entry-level healthcare credentials, fast lpn programs offer a way to quickly become a Licensed Practical Nurse. These diverse, online learning opportunities give students practical, career-focused alternatives, making healthcare education more accessible than ever.

Best Scientists Citing Vesa Kataja

Trending Scientists

Recently Published Articles